“…The seemingly logical strategy would be to replace deficiencies of key nutrients (such as amino acids, proteins, vitamins, minerals, and trace elements) in the doses required, within the appropriate time, and in the manner (early oral feeding, enteral, and/or parenteral) most conducive to helping prevent cellular injury and clinical consequences. But given so many complicating factors, many immune-enhancing and immune-modulating formulas have been developed for use in critically ill and injured patients (Dogjani et al 2011). Patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) should be on an enteral formulation characterized by an antiinflammatory lipid profile (i.e., omega-3 fish oil, borage oil) and antioxidants (Gadek et al 1999).…”